<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9500169</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20475</journal-id>
<journal-id journal-id-type="nlm-ta">Neurobiol Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurobiol. Dis.</journal-id>
<journal-title-group>
<journal-title>Neurobiology of disease</journal-title>
</journal-title-group>
<issn pub-type="ppub">0969-9961</issn>
<issn pub-type="epub">1095-953X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29274432</article-id>
<article-id pub-id-type="pmc">5803417</article-id>
<article-id pub-id-type="doi">10.1016/j.nbd.2017.12.010</article-id>
<article-id pub-id-type="manuscript">NIHMS931040</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Mouse Model of <italic>DEPDC5</italic>-related Epilepsy: Neuronal Loss of <italic>Depdc5</italic> Causes Dysplastic and Ectopic Neurons, Increased mTOR Signaling, and Seizure Susceptibility</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yuskaitis</surname>
<given-names>Christopher J.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jones</surname>
<given-names>Brandon M.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wolfson</surname>
<given-names>Rachel L.</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Super</surname>
<given-names>Chloe E.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dhamne</surname>
<given-names>Sameer C.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rotenberg</surname>
<given-names>Alexander</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sabatini</surname>
<given-names>David M.</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sahin</surname>
<given-names>Mustafa</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Poduri</surname>
<given-names>Annapurna</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children’s Hospital, Boston, MA 02115, USA</aff>
<aff id="A2">
<label>b</label>Division of Epilepsy and Clinical Neurophysiology and Epilepsy Genetics Program, Boston Children’s Hospital, Boston, MA 02115, USA</aff>
<aff id="A3">
<label>c</label>Department of Neurology, Harvard Medical School, Boston, MA 02115, USA</aff>
<aff id="A4">
<label>d</label>Whitehead Institute for Biomedical Research, 455 Main Street, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA; Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA; Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, MA 02139, USA; Broad Institute, 415 Main Street, Cambridge, MA 02142, USA</aff>
<aff id="A5">
<label>e</label>Neuromodulation Program, Department of Neurology, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA</aff>
<author-notes>
<corresp id="FN1">Corresponding Authors: Mustafa Sahin and Annapurna Poduri, <email>Mustafa.Sahin@childrens.harvard.edu</email>, <email>Annapurna.Poduri@childrens.harvard.edu</email>, Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children’s Hospital, Boston, MA 02115, USA</corresp>
<fn fn-type="equal" id="FN2">
<label>*</label>
<p>equal contributions</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>29</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2019</year>
</pub-date>
<volume>111</volume>
<fpage>91</fpage>
<lpage>101</lpage>
<!--elocation-id from pubmed: 10.1016/j.nbd.2017.12.010-->
<abstract>
<p id="P2"><italic>DEPDC5</italic> is a newly identified epilepsy-related gene implicated in focal epilepsy, brain malformations, and Sudden Unexplained Death in Epilepsy (SUDEP). <italic>In vitro</italic>, DEPDC5 negatively regulates amino acid sensing by the mTOR complex 1 (mTORC1) pathway, but the role of DEPDC5 in neurodevelopment and epilepsy has not been described. No animal model of <italic>DEPDC5</italic>-related epilepsy has recapitulated the neurological phenotypes seen in patients, and germline knockout rodent models are embryonic lethal. Here, we establish a neuron-specific <italic>Depdc5</italic> conditional knockout mouse by cre-recombination under the <italic>Synapsin1</italic> promotor. <italic>Depdc5<sup>f</sup></italic><sup>lox/flox</sup>-<italic>Syn1</italic><sup>Cre</sup> (<italic>Depdc5</italic>cc+) mice survive to adulthood with a progressive neurologic phenotype that includes motor abnormalities (i.e., hind limb clasping) and reduced survival compared to littermate control mice. <italic>Depdc5</italic>cc+ mice have larger brains with increased cortical neuron size and dysplastic neurons throughout the cortex, comparable to the abnormal neurons seen in human focal cortical dysplasia specimens. <italic>Depdc5</italic> results in constitutive mTORC1 hyperactivation exclusively in neurons as measured by the increased phosphorylation of the downstream ribosomal protein S6. Despite a lack of increased mTORC1 signaling within astrocytes, <italic>Depdc5</italic>cc+ brains show reactive astrogliosis. We observed two <italic>Depdc5</italic>cc+ mice to have spontaneous seizures, including a terminal seizure. We demonstrate that as a group <italic>Depdc5</italic>cc+ mice have lowered seizure thresholds, as evidenced by decreased latency to seizures after chemoconvulsant injection and increased mortality from pentylenetetrazole-induced seizures. In summary, our neuron-specific <italic>Depdc5</italic> knockout mouse model recapitulates clinical, pathological, and biochemical features of human <italic>DEPDC5</italic>-related epilepsy and brain malformations. We thereby present an important model in which to study targeted therapeutic strategies for <italic>DEPDC5</italic>-related conditions.</p>
</abstract>
<kwd-group>
<kwd>DEPDC5</kwd>
<kwd>Focal cortical dysplasia</kwd>
<kwd>mTOR</kwd>
<kwd>Familial focal epilepsy</kwd>
<kwd>Seizures</kwd>
<kwd>Conditional knockout</kwd>
<kwd>Megalencephaly</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>